Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Cash (2016 - 2025)

Historic Change in Cash for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $51.9 million.

  • InspireMD's Change in Cash rose 51293.86% to $51.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.6 million, marking a year-over-year increase of 230449.72%. This contributed to the annual value of $9.3 million for FY2024, which is 8522.36% up from last year.
  • According to the latest figures from Q3 2025, InspireMD's Change in Cash is $51.9 million, which was up 51293.86% from -$874000.0 recorded in Q2 2025.
  • In the past 5 years, InspireMD's Change in Cash ranged from a high of $51.9 million in Q3 2025 and a low of -$28.4 million during Q3 2021
  • Over the past 5 years, InspireMD's median Change in Cash value was -$874000.0 (recorded in 2025), while the average stood at $2.7 million.
  • As far as peak fluctuations go, InspireMD's Change in Cash skyrocketed by 142275.6% in 2021, and later plummeted by 250278.88% in 2025.
  • Over the past 5 years, InspireMD's Change in Cash (Quarter) stood at -$1.1 million in 2021, then surged by 166.16% to $698000.0 in 2022, then plummeted by 701.58% to -$4.2 million in 2023, then surged by 173.78% to $3.1 million in 2024, then skyrocketed by 1575.08% to $51.9 million in 2025.
  • Its Change in Cash was $51.9 million in Q3 2025, compared to -$874000.0 in Q2 2025 and -$6.5 million in Q1 2025.